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Cells:
B16F10 were cultured in DMEM2 with 5% Nu -Serum, 
5% FBS, 10%vOpti-mem, and 1x Glutamax in a 
humidifier incubator (37oC) with 5% CO2. They were 
split 1:5 Mondays and Wednesdays and 1:10 on Fridays.
Melanoma Tumors:
C57BI/6 mice (6-9 weeks old) were bred and maintained 
in the Division of Biology at K-State. Mice were kept in 
a 12 hour light-dark cycle with constant access to rodent 
food and water. The Institutional Animal Care and Use 
Committee (IACUC) approved all procedures and 
complied with the Animal Welfare Act. Mice were 
injected with 2x106 B16F10 cells in Matrigel (1:1) and 
tumors were measured daily for 10 days prior to 
removing tumors. Peptides were given to mice by retro-
orbital injection on multiple days during the 10 day 
period. Tumor weight and pictures were recorded of each 
animal after removal. 
β2-GPI and C3 and IgM Immunohistochemistry:
Tissues were incubated with 10% Donkey sera in PBS 
for 30 minutes at 37oC to block non-specific antibody 
binding. Tissues were covered with a primary antibody  
or an appropriate isotype control antibody. The primary 
antibody is specific for the antigen and the isotype 
antibody serves as a negative control and is not specific. 
After washing, a secondary antibody is added to the 
slides at room temperature and in darkness to prevent 
fluorescence wash out. Slides were then cover slipped. 
Pictures were of the taken of the melanoma tumors using 
Infinity Analyze program and a Nikon Eclipse 80i 
fluorescent microscope. 
• Increase sample size for C3 and IgM immunochemistry.
• Compare C3 and IgM in tumors from males vs females.
• Conduct more C3 and IgM IHC with tumors treated with 
and without peptides.
This research was supported by the following:  NIH Grants 5R25GM119968-
02 and P20GM103418. Peptides were produced by John Tomich and the 
Biotechnology Core Center at Kansas State University. Any opinions, findings, 
and conclusions or recommendations expressed in this material are those of the 
author(s) and do not necessarily reflect the views of the National Institute of 
Health.
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Melanoma Tumors express C3 and IgM by Immunochemistry. C3  
and IgM demonstrated bright fluorescent co-localization on the tumors 
that were stained with both the primary and secondary antibodies. The 
tumors stained with control antibodies displayed a very dim fluorescent. 
This suggest C3 and IgM are both present within a melanoma tumor. 
Representative of 4 tumors with 6-8 pictures per tumor.
B2–GPI plays a role in hypoxic tissue 
damage and that blocking B2–GPI may 
decrease tumor growth.
• Male tumors grew faster and larger than female tumors.
• Peptides 296c-s and RD-p9 decreased melanoma tumor 
growth and weight suggesting therapeutic potential.
• Both C3 and IgM are present in female melanoma tumors.
The risk of melanoma, a form of skin cancer, increases with age but tanning beds and 
other forms of tanning increase the risk for young people too.  This deadly cancer kills 
almost 10,000 people each year. Skin cancer tumors develop in melanocytes, which 
produce the skin pigment. Tumor growth primarily depends on the growth of new blood 
vessels (angiogenesis). 
β2-GPI, a protein in high concentration in the blood, binds to hypoxic tissues or 
damaged endothelial cells.  Studies have shown β2-GPI can induce or inhibit 
angiogenesis. Peptides 296c-s and RD-p9 were derived from the binding region of β2-GPI 
(red line) to inhibit β2-GPI activity.
C3 complement activation is a part of complement cascade that begins inflammation 
and is central to complement activation when the antibody, IgM is present. IgM activates 
the classical complement pathway and is one of the isotypes in the initial antigen-antibody 
complexes. In male mice tissue damage is via IgM recognition of β2-GPI with 
complement activation. Clinical studies and other animal models indicate sex hormones 
alter vessel dilation during reperfusion β2-GPI binding and complement activation may 
differ by sex due to different anatomy between genders. We hypothesize that β2-GPI, C3, 
and IgM all play a significant role in melanoma cancer. By blocking β2-GPI we can 
significantly decrease melanoma tumor growth.
Results
Atsumi, T. et al  Autoimmunity (2005) 38:377
Female Melanoma Tumors Express
C3 and IgM
On the 10th day the melanoma tumors were removed from each mice. 
Tumor pictures were recorded for each tumor. Tumors treated with saline 
and p16ss appear to be significantly larger than the tumors treated with the 
blocking peptides 296c-s and RD-p9. Representative of 4-6 tumors per 
peptide.
β2-GPI Peptides Decreased Melanoma 
Tumor Size
Female Tumor Growth






























































β2-GPI Peptides Effect on Melanoma TumorsMelanoma Tumor Size 
Varies by Sex and  β2-GPI Peptides
Male 296c-s
Female p16ss




Mice were injected with 2x106 B16F10 cells and tumors were measured 
each day for 10 days until removed. Tumors were measured daily over 
the course of 10 days. The weight of each tumor was recorded on the 10th
day after the removal of the tumor from the mouse. Peptides 296c-s and 
RD-p9 showed a significant decrease in tumor growth compared to the 
controls saline and p16ss. Males demonstrated a larger growth in both 
volume and weight. Representative of 4-7 tumors per peptide.
